{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:15:29Z","timestamp":1792610129041,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31070741"],"award-info":[{"award-number":["31070741"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31270891"],"award-info":[{"award-number":["31270891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81000560"],"award-info":[{"award-number":["81000560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejphar.2014.04.017","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T19:15:30Z","timestamp":1397934930000},"page":"38-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Chlorpromazine confers neuroprotection against brain ischemia by activating BKCa channel"],"prefix":"10.1016","volume":"735","author":[{"given":"Hua-Juan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Qiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.04.017_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2202-7-28","article-title":"Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation","volume":"7","author":"Bastianetto","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejphar.2014.04.017_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3940(93)90918-B","article-title":"Voltage dependencies of the effects of chlorpromazine on the nicotinic receptor channel from mouse muscle cell line So18","volume":"160","author":"Benoit","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2014.04.017_bib3","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/sj.npp.1301639","article-title":"The evolution of drug development in schizophrenia: past issues and future opportunities","volume":"33","author":"Carpenter","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.04.017_bib4","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cddis.2009.10","article-title":"Baifuzi reduces transient ischemic brain damage through an interaction with the STREX domain of BKCa channels","volume":"1","author":"Chi","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2014.04.017_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1781(79)90024-6","article-title":"Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: positron emission tomography studies","volume":"1","author":"Comar","year":"1979","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2014.04.017_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2165\/00003088-197803010-00002","article-title":"Plasma level monitoring of antipsychotic drugs","volume":"3","author":"Cooper","year":"1978","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2014.04.017_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0306-3623(96)00530-7","article-title":"Serotonin depletion after prolonged chlorpromazine treatment in a simpler model system","volume":"29","author":"Croll","year":"1997","journal-title":"Gen. Pharmacol"},{"key":"10.1016\/j.ejphar.2014.04.017_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.2042-7158.1970.tb08496.x","article-title":"Plasma protein binding of chlorpromazine","volume":"22","author":"Curry","year":"1970","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.017_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/gm302","article-title":"Recycling side-effects into clinical markers for drug repositioning","volume":"4","author":"Duran-Frigola","year":"2012","journal-title":"Genome Med."},{"key":"10.1016\/j.ejphar.2014.04.017_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/86546","article-title":"Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels","volume":"7","author":"Gribkoff","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2014.04.017_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005053-196410000-00011","article-title":"Determination of serum chlorpromazine metabolities in psychotic patients","volume":"139","author":"Huang","year":"1964","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ejphar.2014.04.017_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2014.04.017_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-201X.2001.00914.x","article-title":"Inhibition of human alpha(1E) subunit-mediated Ca2+ channels by the antipsychotic agent chlorpromazine","volume":"173","author":"McNaughton","year":"2001","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2014.04.017_bib14","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1111\/j.1476-5381.1995.tb17214.x","article-title":"Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated K+ current in rat phaeochromocytoma cells","volume":"116","author":"Nakazawa","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.017_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1476-5381.1988.tb11401.x","article-title":"Effect of chlorpromazine on sympathetic neuroeffector transmission in the rabbit isolated pulmonary artery and aorta","volume":"93","author":"Nedergaard","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.017_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tips.2013.03.004","article-title":"Challenges and opportunities of drug repositioning","volume":"34","author":"Novac","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.04.017_bib17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.1993.tb13755.x","article-title":"Differential inhibition of a transient K+ current by chlorpromazine and 4-amino-pyridine in neurones of the rat dorsal root ganglia","volume":"109","author":"Ogata","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.04.017_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/09687860500370703","article-title":"Activation of a mechanosensitive BK channel by membrane stress created with amphipaths","volume":"22","author":"Qi","year":"2005","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.ejphar.2014.04.017_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0005-2736(96)00205-2","article-title":"Chlorpromazine activates chloride currents in Xenopus oocytes","volume":"1324","author":"Quamme","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2014.04.017_bib20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.STR.31.6.1411","article-title":"Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat","volume":"31","author":"Reglodi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2014.04.017_bib21","first-page":"827","article-title":"The protective action of chlorpromazine on the spinal cord of rabbits submitted to ischemia and reperfusion is dose-dependent","volume":"43","author":"Sader","year":"2002","journal-title":"J. Cardiovasc. Surg. (Torino)"},{"key":"10.1016\/j.ejphar.2014.04.017_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0010-440X(99)90082-2","article-title":"A history of antipsychotic drug development","volume":"40","author":"Shen","year":"1999","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.017_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/187152707781387323","article-title":"Novel targets for drugs in schizophrenia","volume":"6","author":"Stone","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ejphar.2014.04.017_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-3223(92)90085-E","article-title":"Drug distribution between blood and brain as a determinant of antipsychotic drug effects","volume":"32","author":"Tsuneizumi","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.04.017_bib25","doi-asserted-by":"crossref","first-page":"e21966","DOI":"10.1371\/journal.pone.0021966","article-title":"Chlorpromazine protects against apoptosis induced by exogenous stimuli in the developing rat brain","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.04.017_bib26","doi-asserted-by":"crossref","first-page":"e28025","DOI":"10.1371\/journal.pone.0028025","article-title":"Systematic drug repositioning based on clinical side-effects","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400301X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400301X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T20:20:14Z","timestamp":1538684414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400301X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":26,"alternative-id":["S001429991400301X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.017","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlorpromazine confers neuroprotection against brain ischemia by activating BKCa channel","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}